Immunogenesis, Inc.
Records under this name other than the patents Immunogenesis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 5 of 5 · Back to Immunogenesis, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,664,204 | Phosphoramidate Alkylator Prodrugs Term ended Term ended Jun 29, 2026 · Medium confidence | Term ended | Term ended Jun 29, 2026 | Medium confidence |
| US 8,299,088 | Compositions and Methods for Treating Cancer Lapsed on the fee record Ended Oct 30, 2024 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2024 | Low confidence |
| US 7,550,496 | Compositions and methods for treating cancer Term ended Term ended Jun 15, 2024 · From the USPTO record | Term ended | Term ended Jun 15, 2024 | From the USPTO record |
| US 8,507,464 | Phosphoramidate Alkylator Prodrugs Term ended Term ended Nov 3, 2023 · Medium confidence | Term ended | Term ended Nov 3, 2023 | Medium confidence |
| US 9,226,932 | Phosphoramidate Alkylator Prodrugs Term ended Term ended Nov 3, 2023 · Medium confidence | Term ended | Term ended Nov 3, 2023 | Medium confidence |